Shares of Cleveland BioLabs Inc (NASDAQ:CBLI) were the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 595,001 shares, a decrease of 30.6% from the April 30th total of 857,159 shares, Stock Ratings News reports. Based on an average trading volume of 187,594 shares, the days-to-cover ratio is presently 3.2 days. Approximately 1.2% of the company’s stock are short sold. Cleveland BioLabs, Inc. (NASDAQ:CBLI) weekly performance is -13.79%. On last trading day company shares ended up $0.496. Analysts mean target price for the company is $2.00. Cleveland BioLabs, Inc. (NASDAQ:CBLI) distance from 50-day simple moving average (SMA50) is -19.56%.
IMRIS Inc. (NASDAQ:IMRS) announced that a published retrospective study indicates that use of VISIUS intraoperative MRI (iMRI) combined with endoscopy for transsphenoidal surgery (surgical access through the nose) increases the amount of pituitary (adenoma) tumor removal compared to conventional microscopy without iMRI. The amount of tumor removal using iMRI was also associated with longer patient survival, according to the article. IMRIS Inc (NASDAQ:IMRS) shares fell -9.78% in last trading session and ended the day on $0.830. IMRIS Inc (NASDAQ:IMRS) quarterly performance is -55.61%.
ON June 3, 2014 MELA Sciences, Inc. (NASDAQ:MELA) developer of the MelaFind(R) system, an optical diagnostic device approved for use in the United States and the European Union to assist dermatologists in melanoma diagnosis, announced that it has initiated a study to examine the real-world clinical impact of MelaFind on dermatologists’ decision to biopsy pigmented skin lesions that are suspicious for melanoma. Darrell Rigel, MD, MS, Clinical Professor of Dermatology at New York University Langone Medical Center, will be the Principle Investigator for the study. MELA Sciences Inc (NASDAQ:MELA) shares moved down -6.99 % in last trading session and was closed at $0.330, while trading in range of $0.32 – $0.35. MELA Sciences Inc (NASDAQ:MELA) year to date (YTD) performance is -48.44%.
Majesco Entertainment Co. (NASDAQ:COOL), an innovative provider of video games for the mass market, will announce its financial results for the second quarter of fiscal 2014 on Monday, June 9, 2014 after the U.S. market close. Majesco Entertainment Co. (NASDAQ:COOL) ended the last trading day at $0.317. Company weekly volatility is calculated as 8.37% and price to cash ratio as 1.21. Majesco Entertainment Co. (NASDAQ:COOL) showed a negative weekly performance of -8.57%.
TOKYO ELECTRON LTD (OTCMKTS:TOELY) On last trading day company shares ended up $16.58 .